Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3739855014 | Product containing only elagolix in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3739856010 | Elagolix only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only elagolix in oral dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| Product containing only elagolix in oral dose form (medicinal product form) | est un(e) (attribut) | Elagolix only product | true | Inferred relationship | Some | ||
| Product containing only elagolix in oral dose form (medicinal product form) | a pour principe actif (attribut) | Elagolix (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only elagolix in oral dose form (medicinal product form) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing only elagolix in oral dose form (medicinal product form) | est un(e) (attribut) | Elagolix-containing product in oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely elagolix sodium 300 milligram/1 each conventional release oral capsule (clinical drug) | est un(e) (attribut) | True | Product containing only elagolix in oral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR